PPD is a holding company. Through its subsidiaries, Co. provides drug development services to the biopharmaceutical industry. Co. provides a suite of clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, and other industry. Co.'s service offerings include both clinical development and laboratory services. Co.'s clinical development services include all phases of development (i.e., Phase I-IV), peri- and post-approval and site and patient access services. Co.'s laboratory services provide a range of testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. The PPD stock yearly return is shown above.
The yearly return on the PPD stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PPD annual return calculation with any dividends reinvested as applicable (on ex-dates).
|